Details of MHC I Antigen Processing and Presentation

Antigen processing and presentation via Major Histocompatibility Complex (MHC) Class I molecules play a crucial role in the adaptive immune response by enabling the immune system to detect and eliminate intracellular pathogens and abnormal cells, such as infected or cancerous cells. This process involves a series of intricate steps that ensure the efficient presentation of antigenic peptides derived from endogenous proteins to cytotoxic T lymphocytes (CD8+ T cells), thereby initiating appropriate immune responses. The journey of antigenic peptides from degradation to presentation by MHC Class I molecules is a meticulously regulated process.

The first step in antigen processing begins with the degradation of endogenous proteins by the immunoproteasome, a specialized form of the proteasome complex found within cells. The immunoproteasome selectively cleaves proteins into shorter peptide fragments, typically 8 to 10 amino acids in length. This proteolytic activity is essential for generating antigenic peptides that can be presented by MHC Class I molecules.

Following proteasomal degradation, the resulting peptide fragments are transported into the endoplasmic reticulum (ER) via the transporter associated with antigen processing (TAP) complex. TAP serves as a gateway for peptide entry into the ER, where peptide loading onto MHC Class I molecules occurs. This process involves the coordinated action of various chaperone proteins, including tapasin, which facilitates the stabilization of MHC Class I molecules and promotes the binding of antigenic peptides.

Within the ER, the nascent MHC Class I molecules undergo peptide loading, where they associate with antigenic peptides generated by the immunoproteasome. Tapasin assists in the quality control of peptide binding, ensuring the selection of high-affinity peptides that can stably interact with MHC Class I molecules. Peptide loading onto MHC Class I molecules occurs in a peptide exchange process, where the previously bound peptide is displaced by the antigenic peptide.

Once loaded with antigenic peptides, the peptide-MHC Class I complexes are transported from the ER through the Golgi apparatus to the cell surface. This transport process involves the formation of transport vesicles that carry the peptide-loaded MHC Class I molecules to the plasma membrane. Along the way, the transport vesicles undergo maturation and fusion with the plasma membrane, ultimately releasing the peptide-MHC Class I complexes onto the cell surface.

At the plasma membrane, the peptide-loaded MHC Class I molecules are displayed for surveillance by CD8+ T cells, the effector cells of the cell-mediated immune response. CD8+ T cells possess T cell receptors (TCRs) that can recognize specific peptide-MHC Class I complexes. Upon encountering a peptide-MHC Class I complex that matches its TCR, a CD8+ T cell becomes activated, triggering a cascade of immune responses aimed at eliminating the source of the antigenic peptide.

In summary, antigen processing and presentation via MHC Class I molecules involve a series of precisely orchestrated steps, starting from the degradation of endogenous proteins by the immunoproteasome to the transport of peptide-loaded MHC Class I molecules to the plasma membrane. This process ensures the effective surveillance of intracellular pathogens and aberrant cells by the immune system, leading to the initiation of adaptive immune responses mediated by cytotoxic T lymphocytes. Understanding the mechanisms underlying antigen processing and presentation via MHC Class I molecules is essential for elucidating immune responses and developing immunotherapeutic strategies against infectious diseases and cancer.

Next Topic: Details of MHC II Antigen Processing and Presentation

Source: ChatGPT response prompted and edited by Joel Graff.

• Immunology (Table of Contents for Entire Course – FREE!)
  • Other Content for Unit 3: Professional Antigen Presenting Cells